+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Insys Therapeutics Inc (INSY) - Product Pipeline Analysis, 2018 Update

1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems of therapeutic compounds. The company harnesses its proprietary sublingual spray technology to develop pharmaceutical cannabinoids. Its flagship product, Subsys, is a sublingual fentanyl spray for breakthrough cancer pain (BTCP). Its lead product candidate, Syndros (dronabinol oral solution), is intended for the treatment of chemotherapy-induced nausea and vomiting (CINV) and anorexia associated with weight loss in AIDS patients. The company offers its products to oncologists, pain specialists and supportive care centers for the potential treatment of addiction to opioids, opioid overdose and epilepsy. It has operations in the US and offers its products in international markets. Insys is headquartered in Chandler, Arizona, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

  • The report analyzes all pipeline products in development for the company Insys Therapeutics Inc

  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

  • The report provides detailed description of products in development, technical specification and functions

  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

  • To formulate effective Research & Development strategies

  • Develop market-entry and market expansion strategies

  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • Insys Therapeutics Inc Company Overview

  • Insys Therapeutics Inc Company Snapshot

  • Insys Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview

  • Insys Therapeutics Inc - Pipeline Analysis Overview

  • Business Description

  • Insys Therapeutics Inc - Key Facts

  • Insys Therapeutics Inc - Major Products and Services

  • Insys Therapeutics Inc Pipeline Products by Development Stage

  • Insys Therapeutics Inc Pipeline Products Overview

  • Buprenorphine Sublingual Spray Device

  • Buprenorphine Sublingual Spray Device Product Overview

  • Buprenorphine/Naloxone Sublingual Spray

  • Buprenorphine/Naloxone Sublingual Spray Product Overview

  • Naloxone Sublingual Spray

  • Naloxone Sublingual Spray Product Overview

  • Ondansetron Sublingual Spray

  • Ondansetron Sublingual Spray Product Overview

  • Insys Therapeutics Inc - Key Competitors

  • Insys Therapeutics Inc - Key Employees

  • Insys Therapeutics Inc - Key Employee Biographies

  • Insys Therapeutics Inc - Locations And Subsidiaries

  • Head Office

  • Other Locations & Subsidiaries

  • Recent Developments

  • Insys Therapeutics Inc, Recent Developments

  • Apr 02, 2018: INSYS Therapeutics Appoints Trudy Vanhove to Board of Directors

  • Mar 08, 2018: INSYS Therapeutics Reports Fourth Quarter and Full Year 2017 Results

  • Feb 09, 2018: INSYS Therapeutics Addresses Maryland Attorney General’s Motion

  • Feb 01, 2018: INSYS Therapeutics Appoints Vaseem Mahboob to Board of Directors

  • Jan 30, 2018: INSYS Therapeutics Announces Senior Management Changes

  • Dec 06, 2017: FDA Accepts New Drug Application (NDA) for Buprenorphine Sublingual Spray from INSYS Therapeutics

  • Nov 02, 2017: INSYS Therapeutics Reports Third Quarter 2017 Results

  • Oct 29, 2017: INSYS Therapeutics Founder Dr. John N. Kapoor Steps Down from Board of Directors

  • Oct 29, 2017: INSYS Therapeutics Announces Resignation of Patrick P. Fourteau from Board of Directors

  • Oct 06, 2017: INSYS Therapeutics Addresses New Jersey Complaint

  • Appendix

  • Methodology

  • About

  • Contact

  • Disclaimer

List of Tables
  • Insys Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview

  • Insys Therapeutics Inc Pipeline Products by Equipment Type

  • Insys Therapeutics Inc Pipeline Products by Indication

  • Insys Therapeutics Inc, Key Facts

  • Insys Therapeutics Inc, Major Products and Services

  • Insys Therapeutics Inc Number of Pipeline Products by Development Stage

  • Insys Therapeutics Inc Pipeline Products Summary by Development Stage

  • Buprenorphine Sublingual Spray Device - Product Status

  • Buprenorphine Sublingual Spray Device - Product Description

  • Buprenorphine/Naloxone Sublingual Spray - Product Status

  • Buprenorphine/Naloxone Sublingual Spray - Product Description

  • Naloxone Sublingual Spray - Product Status

  • Naloxone Sublingual Spray - Product Description

  • Ondansetron Sublingual Spray - Product Status

  • Ondansetron Sublingual Spray - Product Description

  • Insys Therapeutics Inc, Key Employees

  • Insys Therapeutics Inc, Key Employee Biographies

  • Insys Therapeutics Inc, Other Locations

  • Insys Therapeutics Inc, Subsidiaries

  • Glossary

List of Figures
  • Insys Therapeutics Inc Pipeline Products by Equipment Type

  • Insys Therapeutics Inc Pipeline Products by Development Stage

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Teva Pharmaceutical Industries Ltd
  • SELLAS Life Sciences Group Inc
  • Par Pharmaceutical Holdings Inc
  • Mallinckrodt, LLC
  • Depomed Inc
  • BioDelivery Sciences International Inc